The bone marrow environment of mice aged 55–65 weeks permits expansion of transplanted human ER+, triple-negative and Her2-amplified BC cells, and retains non-cycling quiescent cells to a far lesser extent than that of young 4–6 week old mouse recipients [97]. This evidence concerns the gene ERBB2 and breast cancer.